IRIS
DIOTALLEVI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.002
EU - Europa 1.034
AS - Asia 1.022
SA - Sud America 240
AF - Africa 91
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.398
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.959
SG - Singapore 422
CN - Cina 287
IT - Italia 214
BR - Brasile 212
RU - Federazione Russa 190
SE - Svezia 142
IE - Irlanda 137
HK - Hong Kong 112
DE - Germania 74
VN - Vietnam 64
GB - Regno Unito 57
FR - Francia 56
IN - India 48
CI - Costa d'Avorio 45
UA - Ucraina 34
CA - Canada 26
MA - Marocco 26
FI - Finlandia 25
JP - Giappone 22
NL - Olanda 19
AT - Austria 18
ES - Italia 16
PL - Polonia 14
BD - Bangladesh 11
MX - Messico 11
AR - Argentina 10
BE - Belgio 10
IQ - Iraq 10
ZA - Sudafrica 10
GR - Grecia 8
ID - Indonesia 8
TR - Turchia 8
AU - Australia 6
CZ - Repubblica Ceca 6
DK - Danimarca 6
CL - Cile 5
CH - Svizzera 4
CU - Cuba 4
KR - Corea 4
UZ - Uzbekistan 4
CO - Colombia 3
EC - Ecuador 3
EG - Egitto 3
KE - Kenya 3
LT - Lituania 3
PK - Pakistan 3
PY - Paraguay 3
TW - Taiwan 3
VE - Venezuela 3
IL - Israele 2
IR - Iran 2
NI - Nicaragua 2
PH - Filippine 2
SA - Arabia Saudita 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CG - Congo 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
KG - Kirghizistan 1
LB - Libano 1
MY - Malesia 1
NC - Nuova Caledonia 1
NO - Norvegia 1
PE - Perù 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.398
Salva come PNG Salva come JPEG
Città #
Ashburn 399
Dallas 399
Chandler 385
Singapore 284
Des Moines 248
Dublin 129
New York 127
Boardman 120
Hong Kong 111
Fairfield 88
Los Angeles 68
The Dalles 67
Beijing 63
Jacksonville 56
Lawrence 46
Princeton 46
Woodbridge 45
Abidjan 44
Moscow 43
Wilmington 41
Seattle 39
Munich 35
Houston 33
Council Bluffs 30
Ancona 27
Cambridge 27
San Mateo 27
London 26
Hefei 22
Centro 21
Ho Chi Minh City 21
Guangzhou 20
Pune 20
Columbus 19
São Paulo 19
Ann Arbor 18
Hanoi 18
Santa Clara 18
Tokyo 18
Turin 18
Washington 18
Buffalo 17
San Diego 17
Atlanta 13
Chicago 13
Turku 12
Denver 11
Helsinki 11
Montreal 11
Redmond 11
Brussels 10
Kazan' 10
Pesaro 10
Shanghai 10
Vienna 10
Warsaw 10
Boston 9
Boydton 9
Brooklyn 9
Chennai 9
Orem 9
Rome 9
Urbisaglia 9
Johannesburg 8
Nuremberg 8
Rio de Janeiro 8
Stockholm 8
Toronto 7
Wuhan 7
Cagliari 6
Frankfurt am Main 6
Jakarta 6
Norwalk 6
Phoenix 6
San Francisco 6
Amsterdam 5
Biên Hòa 5
Brasília 5
New Delhi 5
Ankara 4
Civitanova Marche 4
Curitiba 4
Elk Grove Village 4
Falkenstein 4
Havana 4
Manchester 4
Milan 4
Mumbai 4
Najaf 4
Naples 4
Olomouc 4
Polverigi 4
Poplar 4
Porto Alegre 4
Querétaro 4
San Vito Chietino 4
Sydney 4
Tashkent 4
Basra 3
Belo Horizonte 3
Totale 3.726
Salva come PNG Salva come JPEG
Nome #
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study 130
miRNome analysis in psoriatic patients treated with anti IL- 23: a cohort study 124
Mesenchymal stem cell profile in actinic keratosis and its modification after topical application of ingenol mebutate 120
Buschke–ollendorff syndrome in a 6-year old patient: Clinical anhistopathological aspects of a rare disease 113
Familial lupus panniculitis: two cases, same diagnosis, what evolution? 112
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 112
Long-term efficacy and safety of apremilast in the treatment of plaques psoriasis: A real-world, single-center experience 112
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 108
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients 105
The efficacy of in vivo administration of Apremilast on mesenchymal stem cells derived from psoriatic patients 103
Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study 102
Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review 101
Reticulated acanthoma with sebaceous differentiation 101
Vaccination against SARS-CoV-2 and psoriasis: the three things every dermatologist should know 101
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 101
Granuloma faciale successfully treated with ingenol mebutate 100
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy 99
Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center 99
Asymptomatic pigmentation of the skin in a child: babywipes, once again 98
Safety update of etanercept treatment for moderate to severe plaque psoriasis 96
Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological clinic of a ii level hospital 96
Novel therapeutic approaches and targets for treatment of chronic urticaria: New insights and promising targets for a challenging disease 95
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience 92
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic 92
Topical application of fumaric acid esters improves appearance of nail psoriasis 92
Acral Leukoderma: Is It Always Vitiligo? 92
Novel Therapeutic Approaches and Targets for Treatment of Psoriasis 91
Ixekizumab for treatment of moderate to severe plaque psoriasis: real world clinical experience. 90
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 88
Humoral and cellular immunity after mRNA COVID-19 vaccine in psoriatic patients on biological or immunosuppressive therapy: a real-life experience 87
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 86
Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience 83
Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities 83
Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau 81
Baricitinib: The first jak inhibitor approved in europe for the treatment of moderate to severe atopic dermatitis in adult patients 80
A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to Bedside 79
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption 79
InflammamiR-146a and -155 Plasma Levels are Associated with Clinical Efficacy of Risankizumab Treatment in Psoriatic Patients: Pilot Study 78
Mesenchymal Stem Cells Profile in Adult Atopic Dermatitis and Effect of IL4-IL13 Inflammatory Pathway Inhibition In Vivo: Prospective Case-Control Study 78
A tricky case of contact dermatitis: Simultaneous allergic reaction to topical and oral acyclovir, and scar gel 78
Psoriasis as an immune-mediated and inflammatory systemic disease: From pathophysiology to novel therapeutic approaches 77
Pyoderma gangrenosum succesfully treated with golimumab: Case report and review of the literature 73
Skin involvement in patients with psoriatic arthritis: preliminary results of treatment with apremilast in real world setting. 73
Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature 72
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art 71
Vaccines for COVID-19 in patients with atopic dermatitis: Three things every dermatologist should know 71
The role of the optical super high magnification dermoscopy (O.S.H.M.D) in the management of melanocytic lesions 70
How to fight SARS-COV-2 vaccine hesitancy in patients suffering from chronic and immune-mediated skin disease: four general rules 70
Pharmacodynamics of TNF α inhibitors for the treatment of psoriasis 67
Saliva proteomics as fluid signature of inflammatory and immune mediated skin diseases 67
Safety and efficacy of vaccines during covid-19 pandemic in patients treated with biological drugs in a dermatological setting 67
Biological treatments for pediatric psoriasis: state of the art and future perspectives 66
Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management 66
Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review 65
Saliva and Oral Diseases 62
Circulating MicroRNAs in Patients with Psoriasis Treated with Anti-IL-23: A Cohort Study 61
Late Patch Test Reaction to Acrylates in 2 Patients: Should We Schedule a Check at Weeks 2 and 3? 59
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa 58
miRNAs, Mesenchymal Stromal Cells and Major Neoplastic and Inflammatory Skin Diseases: A Page Being Written: A Systematic Review 56
Mesenchymal Stem Cells and Psoriasis: Systematic Review 53
Infliximab-induced eruptive sebaceous hyperplasia in patient treated for ulcerative colitis: first reported case 52
Pain Control during the Treatment of Primary Palmar Hyperhidrosis with Botulinum Toxin A by a Topical Application of Liposomal Lidocaine: Clinical Effectiveness 48
Role of Daptomycin in Cutaneous Wound Healing: A Narrative Review 48
Role of daptomycin in cutaneous wound healing: a narrative review 47
Clinical-epidemiological aspects of the Monkeypox 2022 epidemic: A multicentre study by the Italian SIDeMaST Group of Sexually Transmitted, Infectious and Tropical Diseases 45
Trichorhinophalangeal syndrome: a case report and brief literature review. 44
The pharmacological treatment and management of hyperhidrosis 40
Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study 36
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study—IL PSO (Italian Landscape PSOriasis) 18
Totale 5.559
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.893
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.893
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021189 0 0 0 0 0 2 9 19 29 27 73 30
2021/2022368 10 41 3 2 42 21 3 28 28 7 98 85
2022/20231.090 81 112 67 104 61 335 1 51 191 2 56 29
2023/2024650 88 11 59 59 81 179 13 55 4 24 23 54
2024/20251.330 152 119 35 42 83 51 128 63 252 89 163 153
2025/20261.736 337 210 387 314 408 80 0 0 0 0 0 0
Totale 5.559